Publications, press articles, rankings, awards
20
03, 2024
The EPO will accelerate the processing of oppositions if it is informed of parallel infringement or revocation proceedings before the Unified Patent Court or a national court or competent authority of a contracting state.
6
03, 2024
On 6 December 2023, the General Court of the European Union dismissed two invalidity actions brought by BB Services GmbH against two three-dimensional trademarks relating to toy figures, on the grounds that their shapes are not exclusively dictated by the nature of the product itself or by a shape necessary
(more)22
02, 2024
Procedural order, 25 January 2024 – Düsseldorf Local Division – UPC_CFI_452/2023
20
02, 2024
The EPO has published a simplified fee system newly introducing reduced fees for micro-entities.
14
02, 2024
Cour de Cassation, Commercial Chamber, 31 January 2024 – Decision No. 22-20.293
8
02, 2024
The Italy and the Unified Patent Court (UPC) have signed a headquarters agreement, see press release of the Italian government.
31
01, 2024
The Pharma and Biotech Patent Litigation Europe summit which has taken place in Amsterdam was a good opportunity to get an overview from the EPO of the state of play.
12
01, 2024
Recently, the annual IP5 Statistics Report of the world’s five largest IP offices (IP5) was issued.
26
12, 2023
Lavoix presents a review of pharmaceutical trademark and design decisions handed down by French and European Union courts.
19
12, 2023
The EPO has announced that the notice from the EPO informing about the entry into the European phase before the EPO is discontinued.